Low molecular weight heparin: laboratory properties and clinical evaluation. A review.
Hirsh
J
J
Hamilton Civic Hospitals, McMaster University, Ontario, Canada.
Levine
M N
MN
D000818:Animals; D004334:Drug Administration Schedule; D006493:Heparin / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use*; D006496:Heparinoids / Q000493:pharmacokinetics / Q000627:therapeutic use; D006801:Humans; D011183:Postoperative Complications / Q000517:prevention & control*; D016032:Randomized Controlled Trials as Topic; D013924:Thrombophlebitis / Q000209:etiology / Q000517:prevention & control*
D006495:Heparin, Low-Molecular-Weight; D006496:Heparinoids; D006493:Heparin